Avalo Therapeutics, Inc. (AVTX) SEC Filings https://ir.avalotx.com/sec-filings/all-sec-filings/rss Avalo Therapeutics, Inc. (AVTX) - All SEC filings en-us https://d1io3yog0oux5.cloudfront.net/_ea697aa916e28469528b0006da59afb9/avalotx/files/theme/images/logo-sm.png Avalo Therapeutics, Inc. Logo Equisolve Investor Relations Suite <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001810417-26-000008/0001810417-26-000008.pdf Fri, 01 May 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001810417-26-000008/0001810417-26-000008.pdf <![CDATA[144 - Report of proposed sale of securities]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001950047-26-003835/0001950047-26-003835.pdf Wed, 29 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001950047-26-003835/0001950047-26-003835.pdf <![CDATA[8-K - Current report]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000026/0001534120-26-000026.pdf Tue, 28 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000026/0001534120-26-000026.pdf <![CDATA[ARS - Annual Report to Security Holders]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000024/0001534120-26-000024.pdf Fri, 10 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000024/0001534120-26-000024.pdf <![CDATA[DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000023/0001534120-26-000023.pdf Fri, 10 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000023/0001534120-26-000023.pdf <![CDATA[DEF 14A - Definitive proxy statements]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000022/0001534120-26-000022.pdf Fri, 10 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001534120-26-000022/0001534120-26-000022.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001918845-26-000008/0001918845-26-000008.pdf Wed, 08 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001918845-26-000008/0001918845-26-000008.pdf <![CDATA[144 - Report of proposed sale of securities]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001950047-26-003276/0001950047-26-003276.pdf Mon, 06 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001950047-26-003276/0001950047-26-003276.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001810417-26-000006/0001810417-26-000006.pdf Fri, 03 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001810417-26-000006/0001810417-26-000006.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001918845-26-000006/0001918845-26-000006.pdf Fri, 03 Apr 26 00:00:00 -0400 https://ir.avalotx.com/sec-filings/all-sec-filings/content/0001918845-26-000006/0001918845-26-000006.pdf